Biocryst Pharmaceuticals Inc (BCRX) · Fund holders
Which of the 64 well-known fund managers followed here own Biocryst Pharmaceuticals, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
3
of 64 funds
Their stake
$9.08M
together
Bought
1
1 new, 0 added
Sold
2
0 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Bridgewater Associates2026-06-30 | 0.02% | 491,057 | $4.91M | Reduced 23% |
| Point72 Asset Management (Steve Cohen)2026-06-30 | 0.00% | 260,917 | $2.61M | New |
| Gotham Asset Management (Joel Greenblatt)2026-06-30 | 0.00% | 156,421 | $1.56M | Reduced 50% |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›